Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

BVMF/ABTT34 stock hub

BVMF/ABTT34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/ABTT34is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

719.3B

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/ABTT34

In the news

Latest news · BVMF/ABTT34

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15

P25 11.3P50 14.6P75 19.6

Trailing P/E22.1

P25 15.2P50 21.5P75 27.3

ROE12.3

P25 5.3P50 12.3P75 22.5

ROIC9.6

P25 7P50 12.5P75 22.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/ABTT34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

231

Groups with data

Currency

USD

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	BR
Employees	115,000
Employees Change	7,000%
Employees Change Percent	6.09
Enterprise value	BRL 853.9B
Exchange	Brazil Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical Devices
Last refreshed	2026-05-10
Market cap	BRL 719.3B
Price	BRL 34.4
Price currency	BRL
Rev Per Employee	2,047,405.79x
Sector	Healthcare
Sic	3845
Symbol	bvmf/ABTT34
Website	https://www.abbott.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.53%
EV Earnings	26.18x
EV/EBIT	20.32x
EV/EBITDA	14.37x
EV/FCF	22.19x
EV/Sales	3.86x
FCF yield	5.35%
Forward P/E	14.97x
P/B ratio	2.62x
P/E ratio	22.05x
P/S ratio	3.06x
PE Ratio10 Y	50.34x
PE Ratio3 Y	27.72x
PE Ratio5 Y	27.88x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	19.01%
EBITDA Margin	26.02%
FCF margin	16.35%
Gross margin	56.5%
Gross Profit	BRL 133B
Gross Profit Growth	7.63%
Gross Profit Growth Q	6.52%
Gross Profit Growth3 Y	3.39%
Gross Profit Growth5 Y	3.61%
Net Income	BRL 32.6B
Net Income Growth	-53.52%
Net Income Growth Q	-18.72%
Net Income Growth3 Y	2.62%
Net Income Growth5 Y	1.88%
Pretax Margin	18.03%
Profit Margin	13.91%
Profit Per Employee	BRL 283,608
ROA	5.59
Roa5y	6.84
ROCE	9.32
ROE	12.33
Roe5y	19.7
ROIC	9.63
Roic5y	14.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	13.69%
Cagr1y	-45.5%
Cagr3y	-7.81%
Cagr5y	-6.8%
Div CAGR10	9.03%
Div CAGR3	8.57%
Div CAGR5	8.28%
EPS Growth	-53.65
EPS Growth Q	-19.74
EPS Growth3 Y	2.78
EPS Growth5 Y	2.27
FCF Growth	10.83%
FCF Growth Q	-1.82%
FCF Growth3 Y	2.64%
FCF Growth5 Y	-0.61%
OCF Growth	5.74%
OCF Growth Q	-7.2%
OCF Growth10 Y	12.67%
OCF Growth3 Y	3.01%
OCF Growth5 Y	-0.74%
Revenue Growth	6.59x
Revenue Growth Q	7.78x
Revenue Growth3 Y	2.83x
Revenue Growth5 Y	3.87x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.47
Assets	BRL 576.1B
Cash	BRL 38.1B
Current Assets	BRL 125.4B
Current Liabilities	BRL 90.3B
Debt	BRL 178.1B
Debt EBITDA	BRL 2.81
Debt Equity	BRL 0.65
Debt FCF	BRL 4.63
Equity	BRL 274.9B
Interest Coverage	16.01
Liabilities	BRL 301.2B
Long Term Assets	BRL 450.7B
Long Term Liabilities	BRL 210.8B
Net Cash	BRL -140B
Net Cash By Market Cap	BRL -19.47
Net Debt EBITDA	BRL 2.29
Net Debt Equity	BRL 0.51
Net Debt FCF	BRL 3.64
Tangible Book Value	BRL -5.4B
Tangible Book Value Per Share	BRL -3.1
WACC	6.5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.39
Inventory Turnover	2.88
Net Working Capital	BRL 22.3B
Quick ratio	0.84
Working Capital	BRL 37.2B
Working Capital Turnover	BRL 27.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.03%
Dividend Growth	0.18%
Dividend Growth Years	6%
Dividend per share	BRL 0.73
Dividend Years	15
Dividend Yield	2.12%
Ex Div Date	2026-04-14
Last Dividend	BRL 0.18
Payout Frequency	Quarterly
Payout Ratio	66.73%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	260.57%
1Y total return	-45.48%
200-day SMA	53.96
3Y total return	-21.66%
50-day SMA	43.83
50-day SMA vs 200-day SMA	50under200
5Y total return	-29.68%
All Time High	67.65
All Time High Change	-49.15%
All Time High Date	2025-02-28
All Time Low	5.57
All Time Low Change	517.93%
All Time Low Date	2013-01-28
ATR	0.95
Beta	0.65
Ch YTD	-40.03
High	36.24
High52	64.23
High52 Date	2025-05-21
High52ch	-46.44%
Low	34.4
Low52	34.4
Low52 Date	2026-05-08
Low52ch	0%
Ma50ch	-21.51%
Price vs 200-day SMA	-36.25%
RSI	18.5
RSI Monthly	29.78
RSI Weekly	16.26
Sharpe ratio	-2x
Sortino ratio	-2.26
Total Return	2.08%
Tr YTD	-39.56
Tr1m	-21.47%
Tr1w	-4.87%
Tr3m	-28.02%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 44.8B
Operating Income Growth	9.76
Operating Income Growth Q	-18.26
Operating Income Growth3 Y	3.54
Operating Income Growth5 Y	4.05
Operating margin	19.01

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,731,228,666%
Net Borrowing	87,949,437,400
Shares Insiders	0.49%
Shares Institutions	80.5%
Shares Qo Q	0%
Shares Yo Y	0.03%
Short Ratio	1.85

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 34.9B
Average Volume	1,692.8x
Bv Per Share	155.9
CAPEX	BRL -10.9B
Ch10y	212.7
Ch1m	-21.82
Ch1w	-4.87
Ch1y	-46.22
Ch3m	-28.33
Ch3y	-24.76
Ch5y	-33.97
Ch6m	-38.13
Change	-4.12%
Change From Open	-5.08
Close	35.88
Days Gap	1
Depreciation Amortization	15,543,614,600
Dollar Volume	35,604
Earnings Date	2026-04-16
EBIT	BRL 44.8B
EBITDA	BRL 61.3B
EPS	BRL 18.62
F Score	5
FCF	BRL 38.5B
FCF EV Yield	4.51x
Financing CF	68,125,211,775
Fiscal Year End	December
Founded	1,888
Goodwill	173,083,038,200
Graham Number	21.48084
Graham Upside	-37.56
Income Tax	BRL 9.7B
Investing CF	-116,207,766,100
Is Primary Listing	0
Last Earnings Date	2026-04-16
Last Report Date	2026-03-31
Last Split Date	2022-11-21
Last Split Type	Forward
Lynch Fair Value	BRL 7.8
Lynch Upside	-77.33
Ma150	51.84
Ma150ch	-33.64%
Ma20	38.82
Ma20ch	-11.39%
Net CF	1,413,732,475
Next Earnings Date	2026-07-15
Open	36.24
P FCF Ratio	18.69
P OCF Ratio	14.57
Payment Date	2026-05-21
Position In Range	0
Ppne	60,823,053,400
Price Date	2026-05-08
Price EBITDA	BRL 11.74
Relative Volume	0.61x
Revenue	235,451,666,150x
SBC By Revenue	1.53x
Share Based Comp	3,609,973,700
Tax By Revenue	4.12x
Tax Rate	22.87%
Tr6m	-37.65%
Volume	1,035
Z Score	3.65

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BVMF/ABTT34 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.1%

$0.73 annual per share

Payout ratio

+66.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+8.3%

6 consecutive years of growth

Total shareholder yield

+2.1%

Next ex-dividend date: 2026-04-14

Performance

BVMF/ABTT34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/ABTT34?

Insider, institutional, and short-interest positioning.

Institutional ownership

+80.5%

Share of float held by funds and institutions

Insider ownership

+0.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BVMF/ABTT34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

18.5

Below 30: short-term oversold

Price vs 200-day MA

-36.3%

50/200-day relationship not available

Beta (5Y)

0.65

Less volatile than the market

Sharpe ratio

-2.00

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/ABTT34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/ABTT34 stock rating?

bvmf/ABTT34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/ABTT34 analysis?

The full report lives at /stocks/bvmf/ABTT34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/ABTT34?

The latest report frames bvmf/ABTT34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/ABTT34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.